Table 3.
Regression analysis on the association between obesity and RVAC.
| Parameters | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| β Coefficient (95% CI) | p-Value | β Coefficient (95% CI) | p-Value | |
| Age | −0.004 (−0.006, −0.002) | <0.001 | −0.002 (−0.004, 0.000) | 0.053 |
| Male sex | −0.004 (−0.061, 0.053) | 0.90 | −0.020 (−0.082, 0.041) | 0.51 |
| Normal weight (ref) | ||||
| Overweight | −0.053 (−0.176, 0.011) | 0.10 | −0.045 (−0.107, 0.018) | 0.16 |
| Obese | −0.095 (−0.168, −0.023) | 0.010 | −0.085 (−0.163, −0.009) | 0.029 |
| Hypertension | −0.069 (−0.139, 0.001) | 0.06 | ||
| Diabetes mellitus | −0.051 (−0.146, 0.043) | 0.29 | ||
| Dyslipidemia | −0.052 (−0.127, 0.022) | 0.17 | ||
| SBP | 0.002 (0.000, 0.004) | 0.03 | 0.001 (−0.001, 0.003) | 0.34 |
| DBP | 0.005 (0.002, 0.009) | <0.001 | 0.004 (−0.002, 0.008) | 0.005 |
| Heart rate | 0.001 (−0.001, 0.003) | 0.22 | ||
| LV EF | 0.019 (0.011, 0.026) | <0.001 | 0.008 (−0.001, 0.017) | 0.09 |
| LV GLS | 0.002 (−0.009, 0.013) | 0.71 | ||
| LVEDDi | 0.001 (−0.010, 0.010) | 0.95 | ||
| LVESDi | −0.006 (−0.018, 0.006) | 0.33 | ||
| IVS | −0.028 (−0.048, −0.008) | 0.006 | 0.007 (−0.025, 0.038) | 0.68 |
| PW | −0.021 (−0.045, 0.003) | 0.08 | ||
| LVMi | −0.002 (−0.003, −0.001) | 0.02 | 0.001 (−0.002, 0.003) | 0.87 |
| LADi | −0.014 (−0.022, −0.007) | <0.001 | −0.004 (−0.016, 0.008) | 0.52 |
| E/e’ | −0.016 (−0.023, −0.009) | <0.001 | −0.009 (−0.017, −0.001) | 0.026 |
| RVD1basal | −0.006 (−0.015, 0.003) | 0.18 | ||
SBP: systolic blood pressure, DBP: diastolic blood pressure, LV EF: left ventricular ejection fraction, LV GLS: LV global longitudinal strain, LVEDDi: LV end-diastolic diameter indexed, LVESD: LV end-systolic diameter indexed, IVS: interventricular septum, PW: posterior wall, LADi: left atrium diameter indexed, RVD1: right ventricular basal diameter at end-diastole.